Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
- PMID: 35039054
- PMCID: PMC8762953
- DOI: 10.1186/s12943-021-01440-5
Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
Abstract
Hypoxia is a remarkable trait of the tumor microenvironment (TME). When facing selective pressure, tumor cells show various adaptive characteristics, such as changes in the expression of cancer hallmarks (increased proliferation, suppressed apoptosis, immune evasion, and so on) and more frequent cell communication. Because of the adaptation of cancer cells to hypoxia, exploring the association between cell communication mediators and hypoxia has become increasingly important. Exosomes are important information carriers in cell-to-cell communication. Abundant evidence has proven that hypoxia effects in the TME are mediated by exosomes, with the occasional formation of feedback loops. In this review, we equally focus on the biogenesis and heterogeneity of cancer-derived exosomes and their functions under hypoxia and describe the known and potential mechanism ascribed to exosomes and hypoxia. Notably, we call attention to the size change of hypoxic cancer cell-derived exosomes, a characteristic long neglected, and propose some possible effects of this size change. Finally, jointly considering recent developments in the understanding of exosomes and tumors, we describe noteworthy problems in this field that urgently need to be solved for better research and clinical application.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Cancer associated-fibroblast-derived exosomes in cancer progression.Mol Cancer. 2021 Dec 1;20(1):154. doi: 10.1186/s12943-021-01463-y. Mol Cancer. 2021. PMID: 34852849 Free PMC article. Review.
-
Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion.Int J Mol Sci. 2022 Oct 4;23(19):11789. doi: 10.3390/ijms231911789. Int J Mol Sci. 2022. PMID: 36233088 Free PMC article. Review.
-
Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment.J Hematol Oncol. 2020 Jun 5;13(1):67. doi: 10.1186/s13045-020-00893-3. J Hematol Oncol. 2020. PMID: 32503591 Free PMC article. Review.
-
Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis.Front Immunol. 2022 Jan 4;12:795372. doi: 10.3389/fimmu.2021.795372. eCollection 2021. Front Immunol. 2022. PMID: 35058933 Free PMC article. Review.
-
The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy.Front Immunol. 2022 Jun 22;13:915985. doi: 10.3389/fimmu.2022.915985. eCollection 2022. Front Immunol. 2022. PMID: 35812406 Free PMC article. Review.
Cited by
-
Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via exosomes in gastrointestinal tumors.Front Oncol. 2024 Feb 23;14:1374742. doi: 10.3389/fonc.2024.1374742. eCollection 2024. Front Oncol. 2024. PMID: 38463229 Free PMC article. Review.
-
Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade.Bioact Mater. 2024 Mar 2;36:126-156. doi: 10.1016/j.bioactmat.2024.02.021. eCollection 2024 Jun. Bioact Mater. 2024. PMID: 38450204 Free PMC article. Review.
-
Exosomes derived from programmed cell death: mechanism and biological significance.Cell Commun Signal. 2024 Mar 1;22(1):156. doi: 10.1186/s12964-024-01521-0. Cell Commun Signal. 2024. PMID: 38424607 Free PMC article. Review.
-
Pharmacological HIF-1 activation upregulates extracellular vesicle production synergistically with adiponectin through transcriptional induction and protein stabilization of T-cadherin.Sci Rep. 2024 Feb 13;14(1):3620. doi: 10.1038/s41598-024-51935-6. Sci Rep. 2024. PMID: 38351156 Free PMC article.
-
Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance.Mol Cancer. 2024 Jan 19;23(1):18. doi: 10.1186/s12943-024-01932-0. Mol Cancer. 2024. PMID: 38243280 Free PMC article. Review.
References
-
- Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393–410. - PubMed
-
- Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4:437–447. - PubMed
-
- Wigerup C, Påhlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 2016;164:152–169. - PubMed
-
- Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med. 1997;3:177–182. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
